References
- Szlachnic J, Tubau J F, Vollmer C, Henderson S, Massie B M. Diltiazem versus propranolol in essential hypertension: Responses of rest and exercise blood pressure and effects on exercise capacity. Am J Cardiol 1987; 59: 393–9
- Davies S F, Graif J L, Husebye D G, Maddy M M, McArthur C D, Path M J. Comparative effects of transdermal clonidine and oral atenolol on acute exercise performance and response to aerobic conditioning in subjects with hypertension. Arch Intern Med 1989; 149: 1551–6
- Leonetti G, Mazzola C, Pasotti C, Angioni L, Vaccarella A, Capra A. Antihypertensive efficacy and influence on physical activity of three different treatments in elderly hypertensive patients. J Hypertens 1989; 7: 304–5, (Suppl 6)
- Todd P A, Faulds D. Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders. Drugs 1992; 44: 251–77
- Nyberg G, Edgar B, Elmfeldt D, Lundborg P, Raner S, Rönn O. The effect of felodipine on the blood pressure reaction to isometric exercise in healthy young men and hypertensive patients. Br J Clin Pharmacol 1984; 17: 189–90
- Lorimer R, McAlpine H, Rae A, Simpson I, Barbour M, Forret E. Effects of felodipine on rest and exercise heart rate and blood pressure in hypertensive patients. Drugs 1985; 29: 154–7, (Suppl 2)
- Jones C R, Rae A, Been M, De Vane P J, Jamieson R R, Hornung R S. Electrophysiological effects of felodipine in combination with metoprolol. Drugs 1985; 29: 81–6, (Suppl 2)
- Koolen J J, Van Wezel H, Piek J, Van Liebergen R, Swaan A, Visser C A. Effects of intracoronary felodipine versus nifedipine on left ventricular contractility and coronary sinus blood flow in stable angina pectoris. Am J Cardiol 1994; 74: 730–2
- Dahlöf B, Jönsson L, Borgholst O, Ekblad G, Engstrand C, Grundestam I. Improved antihypertensive efficacy of the felodipine-metoprolol extended release tablet compared with each drug alone. Blood pressure 1993; 2: 37–45, (Suppl 1)
- Elmfeldt D, Nordlander M, Edgar B. Renal effects of felodipine–a review. Kidney Int 1992; 41: 54–60, (Suppl 36)
- Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med 1970; 2: 92–8
- Hansson B G, Dymling J F, Hedeland H. Long-term treatment of moderate hypertension with the betal-receptor blocking agent metoprolol. Eur J Clin Pharmacol 1977; 11: 239–45
- Katzman P L, Hulthen U L, Hökfelt B. The effects of 8 weeks treatment with the calcium antagonist felodipine on blood pressure, heart rate, working capacity, plasma renin activity, plasma angiotensin II, urinary catecholamines and aldosterone in patients with essential hypertension. Br J Clin Pharmacol 1986; 21: 633–40
- Patel K R, Peers E. Felodipine, a new calcium antagonist, modifies exercise-induced asthma. Am Rev Respir Dis 1988; 138: 54–6
- Patrick J, Bassey J, Morrant J, MacDonald I. Effects of a week's beta-adrenoceptor blockade with atenolol and metoprolol CR/ZOK on the response to exercise in healthy women aged 50 to 70 years. J Clin Pharmacol 1990; 30: 108–16
- Katzman P L, Hulthen U L, Hökfelt B. Effects of the calcium antagonist felodipine on the sympathetic and renin-angiotensin-aldosterone systems in essential hypertension. Acta Med Scand 1988; 223: 125–31
- Hansson B G, Dymling J F, Manhem P, Hökfelt B. Effects of penbutolol and metoprolol on blood pressure, plasma catecholamines and renin activity in hypertensive patients. Eur Heart J 1983; 4: 57–60, (Suppl D)